La Roche-Posay MelaB3 Serum
Correct stubborn dark spots and achieve a more even, radiant complexion with the La Roche-Posay MelaB3 Serum, an intensive treatment specially developed to fight hyperpigmentation at its source. Powered by Melasyl™, an innovative ingredient designed to target excess melanin, and niacinamide (vitamin B3), known for its soothing and tone-correcting properties, this serum helps visibly reduce dark spots, post-acne marks, and uneven skin tone.
The lightweight, fast-absorbing formula delivers powerful results without irritating the skin, making it suitable for sensitive, acne-prone, and combination skin types. With consistent use, the serum helps improve skin clarity, smooth texture, and enhance overall radiance. It performs especially well in Nigeria’s sunny and humid climate, where hyperpigmentation is a common skincare concern.
Carefully selected for customers at Perona Beauty Store, La Roche-Posay MelaB3 Serum is ideal for anyone seeking an effective, dermatologist-recommended solution to dark spots and discoloration while maintaining healthy, balanced skin.
Key Benefits of La Roche-Posay MelaB3 Serum
-
Visibly reduces dark spots and hyperpigmentation
-
Helps even out skin tone and improve clarity
-
Soothes and strengthens the skin barrier
-
Lightweight, fast-absorbing, and non-greasy
-
Suitable for sensitive and acne-prone skin
Key Ingredients of La Roche-Posay MelaB3 Serum
-
Melasyl™ – Targets excess melanin to correct dark spots
-
Niacinamide (Vitamin B3) – Helps calm the skin and improve uneven tone
-
Hydrating Agents – Support moisture balance and skin comfort
How to Use La Roche-Posay MelaB3 Serum
-
Apply 2–3 drops to clean, dry face and neck
-
Gently massage until fully absorbed
-
Use morning and night
-
Follow with moisturizer and broad-spectrum sunscreen during the day
Tip: For best results, pair with gentle cleansers and high-SPF sunscreens from Perona Beauty Store to protect your skin and prevent future dark spots in Nigerian weather conditions.
Reviews
There are no reviews yet.